home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

World Vaccine Congress Lyon

 
  May 26, 2009  
     
 
Terrapinn Ltd, Palais des Congrès de Lyon
5-8 October 2009


World Vaccine Congress Lyon 2009 is not only Europe’s leading vaccine conference. It is a global knowledge experience, business meeting and access vehicle to your marketplace.

Representation from key European Commission and regulatory agencies
DG Research, DG SANCO, ECDC, EDQM, CHMP, VWP, MHRA, PEI, FAMHP and MEB provide vision and clarity on future industry progress and opportunities
 
Europe’s largest commercial vaccine industry congress for decision makers across European and North America regions
Including World class multiple speaker representation from Baxter, GSK Biologicals, MedImmune, Novartis Vaccines and Diagnostics, Pfizer, sanofi pasteur, sanofi Pasteur MSD, Solvay and Wyeth Vaccines
 
Critical market opportunities outlined in billion Euro vaccine market
European policy frameworks, vaccine regulation and authorisation, vaccine R&D innovation and introduction, Influenza market sustainability, corporate growth strategies and funding sources

Please visit the website for full programme and speaker details. http://www.terrapinn.com/2009/wvcl

 
 
Organized by: Terrapinn
Invited Speakers:

2009 key speakers include:

  • Dr Ole Olesen, Scientific Officer, Neglected Infectious Diseases,Infectious Diseases Unit,DG-Research, European Commission
  • Dr Pierluigi Lopalco, Senior Expert,Scientific Advice Unit, European Centre for Disease Prevention and Control
  • Didier Hoch, President, sanofi pasteur MSD and Former President, European Vaccine Manufacturers
  • Dr Philippe Dro, Chief Executive Officer, GlycoVaxyn
  • Dr Matthias Schroff, Chief Executive Officer, Mologen
  • Dr Luc Hessel, Executive Director, Medical and Public Affairs, Europe, sanofi pasteur MSD
  • Dr Joe Cohen, Vice President R&D, Head of Vaccines for Emerging Diseases and HIV, GSK Biologicals
  • Dr Jeffrey Ulmer, Global Head of External Research, Novartis Vaccines and Diagnostics
  • Dr Hartmut Ehrlich, Vice President, Global Research and Development, Baxter BioScience
  • Dr Jeff Southerton, Executive Director, Worldwide Business Development, Pfizer Global R&D
  • Dr Bram Palache, Global Scientific Communication and Public Affairs Director for Influenza Vaccines, Solvay Biologicals
 
Deadline for Abstracts: 2009-06-01
 
Registration:

Please visit the website for full details. http://www.terrapinn.com/2009/wvcl

E-mail: paul.gilbertson@terrapinn.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.